THE INFLUENCE OF SITE OF METASTASIS ON TUMOUR GROWTH AND RESPONSE TO CHEMOTHERAPY.SLACK NH; BROSS IDJ.1975; BRIT. J. CANCER; G.B.; DA. 1975; VOL. 32; NO 1; PP. 78-86; BIBL. 6 REF.Article

THE HETEROGENEITY OF INVASIVE BLADDER CARCINOMA AND DIFFERENT RESPONSES TO TREATMENTSLACK NH; PROUT GR JR.1980; J. UROL.; USA; DA. 1980; VOL. 123; NO 5; PP. 644-652; BIBL. 27 REF.Article

ENDOMETRIAL CANCER. THERAPEUTIC DECISION AND THE STAGING PROCESS IN EARLY DISEASE.LEWIS GC JR; MORTEL R; SLACK NH et al.1977; CANCER; U.S.A.; DA. 1977; VOL. 39; NO 2 SUPPL.; PP. 959-966; BIBL. 21 REF.; (AM. CANCER. SOC. NATL. CONF. RADIAT. ONCOL. PRESENT STATUS FUTURE POTENTIAL. PROC.; SAN FRANCISCO, CALIF.; 1976)Conference Paper

OBSERVATIONS OF PROLONGED USE OF ORAL EMCYT IN PROSTATIC CANCER PATIENTSSLACK NH; BRADY MF; MURPHY GP et al.1982; UROLOGY (RIDGEWOOD); ISSN 0090-4295; USA; DA. 1982; VOL. 20; NO 5; PP. 515-523; BIBL. 24 REF.Article

PREDICTING SURVIVAL FOLLOWING SURGERY FOR BRONCHOGENIC CARCINOMA = PRONOSTIC DE SURVIE APRES CHIRURGIE POUR CANCER BRONCHOGENIQUESLACK NH; CHAMBERLAIN A; BROSS IDJ et al.1972; CHEST; U.S.A.; DA. 1972; VOL. 62; NO 4; PP. 433-438; BIBL. 11REF.Serial Issue

PLACENTA-LIKE ISOENZYME OF ALKALINE PHOSPHATASE IN PROSTATIC CANCERSCHMIDT JD; SLACK NH; MING CHU T et al.1982; J. UROL.; ISSN 0022-5347; USA; DA. 1982; VOL. 127; NO 3; PP. 457-459; BIBL. 10 REF.Article

EXPERIENCES WITH BILATERAL PRIMARY CARCINOMA OF THE BREAST = RESULTATS OBTENUS DANS LE CANCER PRIMITIF BILATERAL DU SEINSLACK NH; BROSS IDJ; NEMOTO T et al.1973; SURG. GYNECOL. OBSTETR.; U.S.A.; DA. 1973; VOL. 136; NO 3; PP. 433-440; BIBL. 14REF.Article

CARCINOPLACENTAL ISOENZYME (REGAN) IN CARCINOMA OF THE PROSTATESLACK NH; MING CHU T; WAJSMAN LZ et al.1981; CANCER; ISSN 0008-543X; USA; DA. 1981; VOL. 47; NO 1; PP. 146-151; BIBL. 11 REF.Article

RETICULUM CELL SARCOMA. A REVIEW OF RADIOTHERAPEUTIC EXPERIENCE = RETICULOSARCOME. REVUE DES RESULTATS DE LA RADIOTHERAPIEREILLY CJ; TINHAN; STUTZMAN L et al.1972; CANCER; U.S.A.; DA. 1972; VOL. 29; NO 5; PP. 1314-1320; BIBL. 23REF.Serial Issue

A COMPARISON OF ESTRAMUSTINE PHOSPHATE VERSUS CIS-PLATINUM ALONE VERSUS ESTRAMUSTINE PHOSPHATE PLUS CIS-PLATINUM IN PATIENTS WITH ADVANCED HORMONE REFRACTORY PROSTATE CANCER WHO HAD HAD EXTENSIVE IRRADIATION TO THE PELVIS OR LUMBOSACRAL AREA = UNE COMPARAISON DU PHOSPHATE D'ESTRAMUSTINE ET DU CIS-PLATINUM SEUL ET DU PHOSPHATE D'ESTRAMUSTINE ASSOCIE AU CIS-PLATINUM CHEZ LES SUJETS AYANT UN CANCER AVANCE DE LA PROSTATE HORMONORESISTANT AYANT SUBI UNE IRRADIATION ETENDUE DU PETIT BASSIN OU DE LA REGION LOMBOSACREESOLOWAY MS; BECKLEY S; BRADY MF et al.1983; JOURNAL OF UROLOGY; ISSN 0022-5347; USA; DA. 1983; VOL. 129; NO 1; PP. 56-61; ABS. ENG; BIBL. 15 REF.; GRAPHArticle

MULTIPLE MARKER EVALUATION IN HUMAN PROSTATE CANCER WITH THE USE OF TISSUE-SPECIFIC ANTIGENSKURIYAMA M; WANG MC; LEE CL et al.1982; JOURNAL OF THE NATIONAL CANCER INSTITUTE; ISSN 0027-8874; USA; DA. 1982; VOL. 68; NO 1; PP. 99-105; BIBL. 22 REF.Article

USE OF HUMAN PROSTATE-SPECIFIC ANTIGEN IN MONITORING PROSTATE CANCERKURIYAMA M; WANG MC; CHING LI LEE et al.1981; CANCER RES.; ISSN 0008-5472; USA; DA. 1981; VOL. 41; NO 10; PP. 3874-3876; BIBL. 14 REF.Article

A COMPARISON OF HYDROXYUREA, METHYL-CHLOROETHYL-CYCLOHEXY-NITROSOUREA AND CYCLOPHOSPHAMIDE IN PATIENTS WITH ADVANCED CARCINOMA OF THE PROSTATELOENING SA; SCOTT WW; DE KERNION J et al.1981; J. UROL.; ISSN 0022-5347; USA; DA. 1981; VOL. 125; NO 6; PP. 812-816; BIBL. 13 REF.Article

COMPARISON OF PROCARBAZINE, IMIDAZOLE-CARBOXAMIDE AND CYCLOPHOSPHAMIDE IN RELAPSING PATIENTS WITH ADVANCED CARCINOMA OF THE PROSTATESCHMIDT JD; SCOTT WW; GIBBONS RP et al.1979; J. UROL.; USA; DA. 1979; VOL. 121; NO 2; PP. 185-189; BIBL. 5 REF.Article

COMPARISON OF ESTRAMUSTINE PHOSPHATE AND VINCRISTINE ALONE OR IN COMBINATION FOR PATIENTS WITH ADVANCED HORMONE REFRACTORY, PREVIOUSLY IRRADIATED CARCINOMA OF THE PROSTATESOLOWAY MS; DE KERNION JB; GIBBONS RP et al.1981; J. UROL.; ISSN 0022-5347; USA; DA. 1981; VOL. 125; NO 5; PP. 664-667; BIBL. 17 REF.Article

COMPARISON OF ESTRAMUSTINE PHOSPHATE, METHOTREXATE AND CIS-PLATINUM IN PATIENTS WITH ADVANCED, HORMONE REFRACTORY PROSTATE CANCER = COMPARAISON ENTRE LE PHOSPHATE D'ESTRAMUSTINE, LE METHOTREXATE ET LE CIS-PLATINUM CHEZ LES SUJETS AYANT UN CANCER AVANCE DE LA PROSTATE HORMONORESISTANTLOENING SA; BECKLEY S; BRADY MF et al.1983; JOURNAL OF UROLOGY; ISSN 0022-5347; USA; DA. 1983; VOL. 129; NO 5; PP. 1001-1006; ABS. ENG; BIBL. 25 REF.; GRAPHConference Paper

TREATMENT OF NEWLY DIAGNOSED METASTATIC PROSTATE CANCER PATIENTS WITH CHEMOTHERAPY AGENTS IN COMBINATION WITH HORMONES VERSUS HORMONES ALONE = TRAITEMENT DU CANCER METASTATIQUE DE LA PROSTATE RECEMMENT DIAGNOSTIQUE PAR CHIMIOHORMONOTHERAPIE COMPAREE AVEC L'HORMONOTHERAPIE SEULEMURPHY GP; BECKLEY S; BRADY MF et al.1983; CANCER; ISSN 0008-543X; USA; DA. 1983; VOL. 51; NO 7; PP. 1264-1272; ABS. ENG; BIBL. 17 REF.; GRAPHArticle

THE ADDITION OF CHEMOTHERAPY TO HORMONAL THERAPY FOR TREATMENT OF PATIENT WITH METASTATIC CARCINOMA OF THE PROSTATE = L'ADJONCTION D'UNE CHIMIOTHERAPIE A L'HORMONOTHERAPIE DANS LE TRAITEMENT DU CANCER METASTATIQUE DE LA PROSTATEGIBBONS RP; BECKLEY S; BRADY MF et al.1983; JOURNAL OF SURGICAL ONCOLOGY; ISSN 0022-4790; USA; DA. 1983; VOL. 23; NO 2; PP. 133-142; ABS. ENG; BIBL. 22 REF.; GRAPHArticle